Once in a while, someone launches a new financial product on the market which sets everyone in the industry talking - recently it was the unveiling of Virgin Money's Big V direct offer cancer cover.
Much of the publicity and press coverage has been negative about either the marketing tactics employed by Virgin – promoting a product which Virgin stresses is not critical illness cover (CIC) only to compare it with critical illness product premiums – or the fact it is not offered through the advised intermediary channel, as well as questioning whether it actually meets the needs of consumers compared with existing protection products. Only a few months ago, discussion on CI products challenged the status quo and asked whether anything could be done to improve what some touted as a dying ...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes